Tanaka S - Search Results

1

EpCAM-targeted therapy for human hepatocellular carcinoma.

Ogawa K, Tanaka S, Matsumura S, Murakata A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanabe M, Arii S. Ogawa K, et al. Among authors: tanaka s. Ann Surg Oncol. 2014 Apr;21(4):1314-22. doi: 10.1245/s10434-013-3430-7. Epub 2013 Dec 27. Ann Surg Oncol. 2014. PMID: 24370904

2

The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression.

Sugimachi K, Tanaka S, Terashi T, Taguchi K, Rikimaru T, Sugimachi K. Sugimachi K, et al. Among authors: tanaka s. Surgery. 2002 Jan;131(1 Suppl):S135-41. doi: 10.1067/msy.2002.119365. Surgery. 2002. PMID: 11821800 Review.

3

Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma.

Tanaka S, Sugimachi K, Maehara S, Harimoto N, Shirabe K, Wands JR, Sugimachi K. Tanaka S, et al. Surgery. 2002 Jan;131(1 Suppl):S142-7. doi: 10.1067/msy.2002.119495. Surgery. 2002. PMID: 11821801 Review.

4

[Current therapeutic strategy of hepatocellular carcinoma with extensive portal thrombus].

Shirabe K, Shimada M, Tanaka S, Maeda T, Maehara Y. Shirabe K, et al. Among authors: tanaka s. Fukuoka Igaku Zasshi. 2002 Oct;93(10):197-203. Fukuoka Igaku Zasshi. 2002. PMID: 12471717 Review. Japanese.

5

The role of MTA1 gene expression in human hepatocellular carcinoma.

Hamatsu T, Rikimaru T, Yamashita Y, Aishima S, Tanaka S, Shirabe K, Shimada M, Toh Y, Sugimachi K. Hamatsu T, et al. Among authors: tanaka s. Oncol Rep. 2003 May-Jun;10(3):599-604. Oncol Rep. 2003. PMID: 12684630

6

A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.

Tanaka S, Shimada M, Shirabe K, Maehara S, Harimoto N, Tsujita E, Sugimachi K, Maehara Y. Tanaka S, et al. Hepatogastroenterology. 2005 May-Jun;52(63):862-5. Hepatogastroenterology. 2005. PMID: 15966221 Clinical Trial.

7

Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis.

Tanaka S, Wands JR, Arii S. Tanaka S, et al. J Hepatol. 2006 Jan;44(1):233-5. doi: 10.1016/j.jhep.2005.09.012. Epub 2005 Nov 2. J Hepatol. 2006. PMID: 16290311 No abstract available.

8

[Novel molecular-targeting peptide therapy for pancreatic cancer metastasis].

Tanaka S, Nakamura N, Kawamura T, Teramoto K, Arii S. Tanaka S, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:283-7. Nihon Rinsho. 2006. PMID: 16457267 Review. Japanese. No abstract available.

9

Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S. Tanaka S, et al. J Natl Cancer Inst. 2006 Apr 5;98(7):491-8. doi: 10.1093/jnci/djj105. J Natl Cancer Inst. 2006. PMID: 16595785

10

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Tanaka S, Arii S. Tanaka S, et al. Int J Clin Oncol. 2006 Apr;11(2):82-9. doi: 10.1007/s10147-006-0566-5. Int J Clin Oncol. 2006. PMID: 16622743 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,809 results

Search Page

Filters